TPO and COVID-19: The results showed significantly decreased levels of free triiodothyronine (FT3) and free thyroxine (FT4) and increased levels of TSH and thyroid peroxidase (TPO) antibodies in patients with COVID-19 six months after the initial infection suggesting autoimmune hypothyroidism [57].